C

China National Accord Medicines Corp Ltd
SZSE:000028

Watchlist Manager
China National Accord Medicines Corp Ltd
SZSE:000028
Watchlist
Price: 25.51 CNY -2.78% Market Closed
Market Cap: ¥14.2B

Balance Sheet

Balance Sheet Decomposition
China National Accord Medicines Corp Ltd

Balance Sheet
China National Accord Medicines Corp Ltd

Rotate your device to view
Balance Sheet
Currency: CNY
Dec-2002 Dec-2003 Dec-2004 Dec-2005 Dec-2006 Dec-2007 Dec-2008 Dec-2009 Dec-2010 Dec-2011 Dec-2012 Dec-2013 Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023 Dec-2024 Dec-2025
Assets
Cash & Cash Equivalents
109
146
81
169
205
255
382
588
712
953
954
1 113
868
2 655
3 155
3 677
7 639
8 443
5 405
4 734
5 442
5 835
7 124
7 297
Cash
0
0
0
0
0
0
0
0
0
0
0
0
0
3
6
6
6
5
7
4 734
5 442
5 835
7 124
7 297
Cash Equivalents
109
146
81
169
205
255
382
588
712
953
954
1 113
868
2 652
3 149
3 671
7 633
8 438
5 398
0
0
0
0
0
Short-Term Investments
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Total Receivables
349
364
349
392
1 378
1 491
2 131
2 886
3 279
4 143
5 077
6 455
7 706
9 291
9 692
9 830
11 426
12 556
16 492
18 575
17 004
21 254
22 056
23 802
Accounts Receivables
270
318
313
343
1 134
1 287
1 873
2 451
2 867
3 579
4 393
5 676
7 018
7 827
7 654
7 589
9 337
10 713
13 815
15 994
13 783
18 171
19 388
21 541
Other Receivables
79
46
36
49
244
204
258
435
412
564
684
779
688
1 464
2 038
2 241
2 089
1 843
2 677
2 581
3 221
3 083
2 667
2 260
Inventory
250
211
162
210
490
574
754
909
1 156
1 313
1 735
1 831
2 322
4 165
4 049
3 782
4 389
5 063
6 285
7 622
7 836
7 989
7 406
8 122
Other Current Assets
67
5
12
25
92
54
43
86
102
74
98
65
96
641
792
1 033
1 042
833
1 080
918
1 426
1 292
991
976
Total Current Assets
775
726
604
796
2 165
2 375
3 310
4 470
5 249
6 482
7 863
9 466
10 992
16 752
17 689
18 321
24 496
26 896
29 262
31 848
31 708
36 370
37 576
40 196
PP&E Net
166
185
178
198
289
348
402
475
601
733
794
917
1 139
1 620
561
594
655
2 756
3 283
3 534
3 449
3 741
3 499
2 710
PP&E Gross
166
185
178
198
289
348
402
475
601
733
794
917
1 139
1 620
561
594
655
2 756
3 283
3 534
3 449
3 741
3 499
2 710
Accumulated Depreciation
100
106
119
123
189
198
222
260
291
343
400
484
583
800
420
466
531
1 295
2 034
2 613
3 088
3 624
3 708
3 649
Intangible Assets
3
3
2
1
48
53
71
117
132
124
160
156
150
415
320
326
319
375
734
670
648
616
480
407
Goodwill
0
0
0
0
0
0
0
34
54
54
85
85
79
825
824
831
834
1 010
2 747
2 776
2 750
2 747
1 859
1 605
Note Receivable
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
7
17
14
16
13
2
Long-Term Investments
79
61
57
76
102
94
101
116
173
182
209
215
231
356
1 593
1 878
2 179
2 500
2 635
2 772
2 908
3 059
3 165
3 360
Other Long-Term Assets
30
10
5
1
39
40
61
57
99
104
183
219
237
346
329
394
448
492
926
1 167
1 139
1 023
965
817
Other Assets
0
0
0
0
0
0
0
34
54
54
85
85
79
825
824
831
834
1 010
2 747
2 776
2 750
2 747
1 859
1 605
Total Assets
1 053
N/A
984
-7%
846
-14%
1 072
+27%
2 643
+147%
2 911
+10%
3 945
+36%
5 268
+34%
6 307
+20%
7 679
+22%
9 296
+21%
11 058
+19%
12 829
+16%
20 313
+58%
21 317
+5%
22 344
+5%
28 930
+29%
34 029
+18%
39 595
+16%
42 784
+8%
42 616
0%
47 571
+12%
47 556
0%
49 096
+3%
Liabilities
Accounts Payable
295
280
269
334
957
1 055
1 437
1 706
2 004
2 495
3 197
3 437
3 989
6 012
6 702
6 144
6 469
6 704
7 697
9 058
15 233
17 952
18 100
20 516
Accrued Liabilities
34
23
22
63
94
105
88
111
129
185
188
201
202
323
294
340
366
404
555
781
998
743
764
683
Short-Term Debt
184
197
23
52
716
749
1 240
2 049
2 424
2 899
2 793
4 240
2 986
4 162
3 919
4 325
6 047
7 092
9 148
10 151
2 133
2 963
3 483
2 880
Current Portion of Long-Term Debt
0
0
2
0
0
0
58
30
0
24
71
8
4
8
36
5
6
612
749
848
913
1 019
944
740
Other Current Liabilities
205
142
172
228
324
363
353
366
485
437
880
600
507
1 518
1 184
1 315
1 871
2 152
2 108
1 541
1 751
1 661
1 511
1 286
Total Current Liabilities
717
642
487
678
2 091
2 272
3 175
4 262
5 042
6 041
7 130
8 487
7 688
12 022
12 136
12 130
14 758
16 964
20 258
22 379
21 028
24 338
24 802
26 105
Long-Term Debt
0
2
0
0
98
78
30
30
30
93
82
0
40
86
15
41
35
1 208
1 335
1 447
1 345
1 452
1 371
912
Deferred Income Tax
0
0
0
0
14
13
16
26
23
20
27
25
24
84
77
72
68
118
206
176
156
146
115
94
Minority Interest
1
1
0
0
22
33
21
55
79
77
63
72
87
519
465
531
2 287
2 663
2 940
3 097
3 319
3 563
3 086
3 015
Other Liabilities
1
1
1
1
27
26
42
48
81
99
218
230
226
250
172
173
164
164
908
759
642
657
512
361
Total Liabilities
719
N/A
646
-10%
488
-24%
679
+39%
2 252
+232%
2 422
+8%
3 285
+36%
4 421
+35%
5 254
+19%
6 329
+20%
7 520
+19%
8 813
+17%
8 064
-8%
12 960
+61%
12 864
-1%
12 947
+1%
17 312
+34%
21 118
+22%
25 646
+21%
27 859
+9%
26 490
-5%
30 156
+14%
29 886
-1%
30 486
+2%
Equity
Common Stock
288
288
288
288
288
288
288
288
288
288
288
288
363
363
363
428
428
428
428
428
428
557
557
557
Retained Earnings
40
55
82
118
92
191
340
527
759
1 053
1 482
1 951
2 538
3 793
4 872
5 787
6 869
7 966
9 109
10 103
11 333
12 590
12 854
13 786
Additional Paid In Capital
15
17
18
18
10
10
32
32
5
9
6
6
1 864
3 198
3 153
3 181
4 321
4 471
4 373
4 372
4 357
4 261
4 261
4 268
Unrealized Security Profit/Loss
10
22
30
30
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
22
8
8
1
0
Other Equity
0
0
0
0
0
0
0
0
0
0
0
0
0
0
65
0
0
46
38
0
0
0
0
0
Total Equity
333
N/A
338
+2%
358
+6%
394
+10%
390
-1%
489
+25%
660
+35%
847
+28%
1 052
+24%
1 350
+28%
1 776
+32%
2 245
+26%
4 765
+112%
7 353
+54%
8 452
+15%
9 397
+11%
11 618
+24%
12 911
+11%
13 948
+8%
14 925
+7%
16 126
+8%
17 415
+8%
17 670
+1%
18 610
+5%
Total Liabilities & Equity
1 053
N/A
984
-7%
846
-14%
1 072
+27%
2 643
+147%
2 911
+10%
3 945
+36%
5 268
+34%
6 307
+20%
7 679
+22%
9 296
+21%
11 058
+19%
12 829
+16%
20 313
+58%
21 317
+5%
22 344
+5%
28 930
+29%
34 029
+18%
39 595
+16%
42 784
+8%
42 616
0%
47 571
+12%
47 556
0%
49 096
+3%
Shares Outstanding
Common Shares Outstanding
288
288
288
288
288
288
288
288
288
288
288
288
363
363
363
428
428
428
428
557
557
557
557
557
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett